A detailed history of Camden National Bank transactions in Zoetis Inc. stock. As of the latest transaction made, Camden National Bank holds 64,632 shares of ZTS stock, worth $11.6 Million. This represents 1.77% of its overall portfolio holdings.

Number of Shares
64,632
Previous 57,005 13.38%
Holding current value
$11.6 Million
Previous $9.65 Million 16.16%
% of portfolio
1.77%
Previous 1.75%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$145.54 - $178.83 $1.11 Million - $1.36 Million
7,627 Added 13.38%
64,632 $11.2 Million
Q1 2024

Apr 30, 2024

SELL
$165.67 - $199.94 $130,050 - $156,952
-785 Reduced 1.36%
57,005 $9.65 Million
Q4 2023

Feb 12, 2024

SELL
$151.44 - $200.09 $141,899 - $187,484
-937 Reduced 1.6%
57,790 $11.4 Million
Q3 2023

Nov 03, 2023

SELL
$167.14 - $192.77 $5,682 - $6,554
-34 Reduced 0.06%
58,727 $10.2 Million
Q2 2023

Aug 09, 2023

SELL
$160.94 - $186.23 $149,030 - $172,448
-926 Reduced 1.55%
58,761 $10.1 Million
Q1 2023

May 08, 2023

BUY
$145.48 - $175.02 $46,408 - $55,831
319 Added 0.54%
59,687 $9.93 Million
Q4 2022

Feb 10, 2023

SELL
$131.14 - $157.47 $39,997 - $48,028
-305 Reduced 0.51%
59,368 $8.7 Million
Q3 2022

Nov 04, 2022

BUY
$148.29 - $182.55 $3,410 - $4,198
23 Added 0.04%
59,673 $8.85 Million
Q2 2022

Aug 09, 2022

BUY
$155.97 - $200.09 $31,505 - $40,418
202 Added 0.34%
59,650 $10.3 Million
Q1 2022

May 05, 2022

SELL
$181.39 - $234.03 $88,155 - $113,738
-486 Reduced 0.81%
59,448 $11.2 Million
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $279,688 - $356,711
-1,444 Reduced 2.35%
59,934 $14.6 Million
Q3 2021

Nov 09, 2021

SELL
$189.29 - $209.69 $311,760 - $345,359
-1,647 Reduced 2.61%
61,378 $11.9 Million
Q2 2021

Aug 09, 2021

SELL
$155.9 - $187.99 $371,665 - $448,168
-2,384 Reduced 3.64%
63,025 $11.7 Million
Q1 2021

Aug 04, 2021

SELL
$144.0 - $169.39 $393,408 - $462,773
-2,732 Reduced 4.01%
65,409 $10.3 Million
Q4 2020

Feb 01, 2021

SELL
$157.07 - $174.35 $1.11 Million - $1.23 Million
-7,069 Reduced 9.4%
68,141 $11.3 Million
Q3 2020

Nov 05, 2020

SELL
$137.1 - $165.37 $110,365 - $133,122
-805 Reduced 1.06%
75,210 $12.4 Million
Q2 2020

Aug 13, 2020

SELL
$111.92 - $142.53 $55,960 - $71,265
-500 Reduced 0.65%
76,015 $10.4 Million
Q1 2020

May 14, 2020

SELL
$92.66 - $144.94 $802,713 - $1.26 Million
-8,663 Reduced 10.17%
76,515 $9.01 Million
Q4 2019

Feb 11, 2020

BUY
$116.25 - $133.25 $125,550 - $143,910
1,080 Added 1.28%
85,178 $11.3 Million
Q3 2019

Oct 11, 2019

SELL
$112.57 - $128.43 $84,314 - $96,194
-749 Reduced 0.88%
84,098 $10.5 Million
Q2 2019

Aug 08, 2019

SELL
$97.98 - $114.28 $16,558 - $19,313
-169 Reduced 0.2%
84,847 $9.63 Million
Q1 2019

May 08, 2019

BUY
$81.56 - $100.67 $37,680 - $46,509
462 Added 0.55%
85,016 $8.56 Million
Q4 2018

Feb 04, 2019

BUY
$79.28 - $95.27 $6.7 Million - $8.06 Million
84,554 New
84,554 $7.23 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Camden National Bank Portfolio

Follow Camden National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Camden National Bank with notifications on news.